Posted by Michael Wonder on 03 Feb 2021
Geistlich Pharma granted FDA breakthrough device designation for Chondro-Gide articular cartilage cover
2 February 2021 - Geistlich Pharma announced that the Chondro-Gide articular cartilage cover has been granted a breakthrough device designation from the U.S. FDA.
Chondro-Gide is a collagen membrane that is used in a single-step cartilage repair technique.
